| Date | Time | Source | Headline | Symbol | Company |
| 17/01/2019 | 09:00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 17/01/2019 | 09:00 | PR Newswire (US) | Asceneuron Appoints Peter Van Vlasselaer as Chairman | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 02/07/2018 | 21:49 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/06/2018 | 00:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 22:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14:13 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 14:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 13:59 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 13:54 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 13:48 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 22/06/2018 | 13:31 | PR Newswire (US) | Lilly Completes Acquisition of ARMO BioSciences | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 18/06/2018 | 22:06 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/06/2018 | 22:04 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/06/2018 | 21:27 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 11/06/2018 | 13:31 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 30/05/2018 | 22:05 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 30/05/2018 | 22:03 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/05/2018 | 14:18 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 23/05/2018 | 13:49 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 15/05/2018 | 21:52 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |
| 14/05/2018 | 16:38 | PR Newswire (US) | WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders | NASDAQ:ARMO | Armo Biosciences, Inc. (delisted) |